Drugs / ODSH
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02164097 | Jan 2015 → Dec 2017 | Wilms tumor, neuroblastoma, refractory malignant neoplasm, sarcoma | New York Medical College | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ODSH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02164097 ↗ |
| Route | Intravenous | “continuous intravenous ODSH infusion” NCT02164097 ↗ |